128 related articles for article (PubMed ID: 15193476)
1. Premenstrual administration of gonadotropin-releasing hormone antagonist coordinates early antral follicle sizes and sets up the basis for an innovative concept of controlled ovarian hyperstimulation.
Fanchin R; Castelo Branco A; Kadoch IJ; Hosny G; Bagirova M; Frydman R
Fertil Steril; 2004 Jun; 81(6):1554-9. PubMed ID: 15193476
[TBL] [Abstract][Full Text] [Related]
2. Hormonal manipulations in the luteal phase to coordinate subsequent antral follicle growth during ovarian stimulation.
Fanchin R; Méndez Lozano DH; Schonäuer LM; Cunha-Filho JS; Frydman R
Reprod Biomed Online; 2005 Jun; 10(6):721-8. PubMed ID: 15970000
[TBL] [Abstract][Full Text] [Related]
3. Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens.
Fanchin R; Cunha-Filho JS; Schonäuer LM; Kadoch IJ; Cohen-Bacri P; Frydman R
Fertil Steril; 2003 Feb; 79(2):316-21. PubMed ID: 12568840
[TBL] [Abstract][Full Text] [Related]
4. Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation.
Fanchin R; Schonäuer LM; Cunha-Filho JS; Méndez Lozano DH; Frydman R
Semin Reprod Med; 2005 Nov; 23(4):354-62. PubMed ID: 16317624
[TBL] [Abstract][Full Text] [Related]
5. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
[TBL] [Abstract][Full Text] [Related]
6. Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.
Gómez-Palomares JL; Acevedo-Martín B; Chávez M; Manzanares M; Ricciarelli E; Hernández ER
Fertil Steril; 2008 Mar; 89(3):620-4. PubMed ID: 17678911
[TBL] [Abstract][Full Text] [Related]
7. [Coordination of follicle antrum: from luteal estradiol to the premenstrual antagonist].
Fanchin R
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S21-3. PubMed ID: 15643681
[TBL] [Abstract][Full Text] [Related]
8. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI; Chantilis SJ; Hurst BS; Dickey RP
Fertil Steril; 2005 Feb; 83(2):321-30. PubMed ID: 15705369
[TBL] [Abstract][Full Text] [Related]
9. Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration.
Lee TH; Wu MY; Chen HF; Chen MJ; Ho HN; Yang YS
Fertil Steril; 2005 Jun; 83(6):1700-7. PubMed ID: 15950639
[TBL] [Abstract][Full Text] [Related]
10. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists.
Fanchin R; Salomon L; Castelo-Branco A; Olivennes F; Frydman N; Frydman R
Hum Reprod; 2003 Dec; 18(12):2698-703. PubMed ID: 14645194
[TBL] [Abstract][Full Text] [Related]
11. Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends.
Checa MA; Prat M; Robles A; Carreras R
Fertil Steril; 2006 Mar; 85(3):573-7. PubMed ID: 16500321
[TBL] [Abstract][Full Text] [Related]
12. Cycle day, estrogen level, and lead follicle size: analysis of 27,790 in vitro fertilization cycles to determine optimal start criteria for gonadotropin-releasing hormone antagonist.
Lyttle Schumacher BM; Mersereau JE; Steiner AZ
Fertil Steril; 2018 Apr; 109(4):633-637. PubMed ID: 29605403
[TBL] [Abstract][Full Text] [Related]
13. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
Vuong TN; Phung HT; Ho MT
Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
[TBL] [Abstract][Full Text] [Related]
14. Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study.
Ludwig M; Katalinic A; Banz C; Schröder AK; Löning M; Weiss JM; Diedrich K
Hum Reprod; 2002 Nov; 17(11):2842-5. PubMed ID: 12407036
[TBL] [Abstract][Full Text] [Related]
15. Follicular growth and development under continuous gonadotropin-releasing hormone antagonist administration.
Weissman A; Ravhon A; Biran G; Levin D; Golan A; Levran D
Fertil Steril; 2007 Dec; 88(6):1677.e15-7. PubMed ID: 17490658
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
17. Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study.
Blockeel C; Polyzos NP; Derksen L; De Brucker M; Vloeberghs V; van de Vijver A; De Vos M; Tournaye H
Hum Reprod; 2014 Jul; 29(7):1500-7. PubMed ID: 24813196
[TBL] [Abstract][Full Text] [Related]
18. [The programming of IVF cycles with antagonists].
Hugues JN
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S19-20. PubMed ID: 15643680
[TBL] [Abstract][Full Text] [Related]
19. Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer.
Huang SY; Huang HY; Yu HT; Wang HS; Chen CK; Lee CL; Soong YK
Taiwan J Obstet Gynecol; 2011 Dec; 50(4):432-5. PubMed ID: 22212313
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists.
Kolibianakis EM; Albano C; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
Fertil Steril; 2004 Jul; 82(1):102-7. PubMed ID: 15236997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
